Susquehanna International Group, LLP Dexcom Inc Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

29 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $23.3 Million - $42.2 Million	363,600 Added 107.64%	701,400 $47 Million
Q2 2024 Aug 15, 2024	SELL	$110.31 - $140.45 $57.7 Million - $73.5 Million	-523,100 Reduced 60.76%	337,800 $38.3 Million
Q1 2024 May 07, 2024	SELL	$114.22 - $140.1 $54.3 Million - $66.6 Million	-475,500 Reduced 35.58%	860,900 $119 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $26.8 Million - $44.1 Million	355,100 Added 36.19%	1,336,400 $166 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $24.1 Million - $38.7 Million	280,600 Added 40.05%	981,300 $91.6 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $41.4 Million - $48.2 Million	367,900 Added 110.55%	700,700 $90 Million
Q1 2023 May 16, 2023	SELL	$104.0 - $122.92 $116 Million - $137 Million	-1,115,200 Reduced 77.02%	332,800 $38.7 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $67.7 Million - $97.7 Million	796,600 Added 122.29%	1,448,000 $164 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $1.3 Million - $1.6 Million	17,000 Added 2.68%	651,400 $52.5 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $14.5 Million - $28.4 Million	214,000 Added 50.9%	634,400 $47.3 Million
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $16.6 Million - $23 Million	-176,500 Reduced 29.57%	420,400 $215 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $7.91 Million - $9.92 Million	60,900 Added 11.36%	596,900 $321 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $14.3 Million - $19.1 Million	-133,600 Reduced 19.95%	536,000 $293 Million
Q2 2021 Aug 11, 2021	BUY	$80.99 - $107.93 $22.1 Million - $29.4 Million	272,400 Added 68.58%	669,600 $286 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $4.49 Million - $5.55 Million	53,000 Added 15.4%	397,200 $143 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $5.45 Million - $7.3 Million	69,900 Added 25.48%	344,200 $127 Million
Q3 2020 Nov 16, 2020	SELL	$95.51 - $112.95 $1.68 Million - $1.99 Million	-17,600 Reduced 6.03%	274,300 $113 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $9.12 Million - $15.3 Million	145,500 Added 99.39%	291,900 $118 Million
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $19,116 - $30,252	400 Added 0.27%	146,400 $39.4 Million
Q4 2019 Feb 14, 2020	SELL	$36.62 - $57.29 $6.61 Million - $10.3 Million	-180,600 Reduced 55.3%	146,000 $31.9 Million
Q3 2019 Nov 14, 2019	BUY	$35.53 - $43.8 $5.98 Million - $7.37 Million	168,300 Added 106.32%	326,600 $48.7 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $2 Million - $2.79 Million	-71,800 Reduced 31.2%	158,300 $23.7 Million
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $4.53 Million - $6.17 Million	161,500 Added 235.42%	230,100 $27.4 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $1.52 Million - $2.1 Million	-56,200 Reduced 45.03%	68,600 $8.22 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $1.35 Million - $2.12 Million	57,800 Added 86.27%	124,800 $17.9 Million
Q2 2018 Aug 14, 2018	SELL	$17.54 - $25.22 $157,860 - $226,980	-9,000 Reduced 11.84%	67,000 $6.36 Million
Q1 2018 May 15, 2018	BUY	$13.06 - $18.54 $782,294 - $1.11 Million	59,900 Added 372.05%	76,000 $5.64 Million
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $1.3 Million - $1.79 Million	-116,600 Reduced 87.87%	16,100 $924,000
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $1.51 Million - $2.52 Million	132,700	132,700 $6.49 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account